Posted on

Oncology Companion Diagnostic Market to Value USD 14.65 Billion by 2035, Registering 11.09% CAGR – SNS Insider

U.S. Market Valued at USD 2.17 Billion in 2025 While Europe Reaches USD 1.47 Billion as Biomarker-Based Cancer Testing Expands. 

U.S. Market Valued at USD 2.17 Billion in 2025 While Europe Reaches USD 1.47 Billion as Biomarker-Based Cancer Testing Expands.

Go to Source

By sf-admin